Form 4: LivaNova Director Stacy Enxing Seng Reports Routine Stock Transactions and New RSU Grant
Insider Transaction Report
LivaNova PLC Director Stacy Enxing Seng reported the vesting of restricted stock units, the acquisition of ordinary shares, and the disposition of shares for tax purposes, alongside a new grant of restricted stock units.
Summary
- LivaNova PLC Director Stacy Enxing Seng reported transactions on June 15, 2025, involving the company's ordinary shares and restricted stock units (RSUs).
- 3,416 restricted stock units (RSUs) granted under the 2015 Incentive Award Plan on June 15, 2024, vested and were settled into 3,416 ordinary shares.
- Following the vesting, 410 ordinary shares were disposed of at a price of $45.76 per share to satisfy tax liabilities.
- The reporting person's direct beneficial ownership of ordinary shares after these transactions is 11,751.
- Additionally, 4,042 new restricted stock units (RSUs) were acquired under the 2025 Director Incentive Award Plan.
- These newly granted RSUs are contingent rights to receive one ordinary share each and are scheduled to vest on June 15, 2026, subject to continued service.
- The reporting person's direct beneficial ownership of derivative securities (RSUs) after these transactions is 4,042.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive. While there's a disposition of shares, it's for tax purposes, which is routine. The core positive is the vesting of existing RSUs into shares and the grant of new RSUs, indicating continued equity-based compensation and alignment of interests, which is generally viewed favorably for a director.
Positives
- The acquisition of 3,416 ordinary shares through the vesting of RSUs indicates a conversion of contingent rights into direct equity ownership.
- The grant of 4,042 new restricted stock units under the 2025 Director Incentive Award Plan demonstrates continued compensation and alignment of the director's interests with shareholder value, subject to future vesting.
Negatives
- 410 ordinary shares were disposed of to cover tax liabilities, which represents a reduction in direct shareholding, albeit a common practice for RSU vesting.
Future Outlook
The document indicates a future vesting event for 4,042 restricted stock units on June 15, 2026, contingent upon the director's continued service during the vesting period and adherence to the terms of the 2025 Director Incentive Award Plan.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, common across all publicly traded companies. It reflects a director's compensation structure, which often includes equity awards like Restricted Stock Units (RSUs) to align management interests with long-term shareholder value. The disposition of shares for tax purposes upon vesting is a standard practice in such equity compensation plans.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as part of director compensation is a common practice in the medical technology and broader corporate sectors, aligning director incentives with company performance.
- The 'net settlement' or 'sell-to-cover' approach for tax withholding upon RSU vesting, as seen with the disposition of 410 shares, is a widely accepted and standard method for managing tax obligations arising from equity compensation across industries.
- The structure of the 2015 Incentive Award Plan and the 2025 Director Incentive Award Plan, which grant contingent rights to shares, is consistent with typical long-term incentive plans designed to retain and motivate key personnel in publicly traded companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Incentive Plan Utilization | The transactions highlight the ongoing use of the company's 2015 Incentive Award Plan and the introduction/utilization of the 2025 Director Incentive Award Plan for equity compensation. | 06/15/2025 | These plans are designed to align the interests of directors with shareholders by providing equity-based compensation, fostering long-term commitment and performance. |
Stakeholder Impact
- **Shareholders:** The filing provides transparency regarding director equity ownership and compensation, which can influence investor confidence. The continued grant of RSUs aligns director incentives with shareholder value.
- **Employees:** While not directly impacting employees, the compensation structure for directors can reflect broader company policies on equity incentives.
Next Steps
- The 4,042 Restricted Stock Units granted on June 15, 2025, are scheduled to vest on June 15, 2026, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 06/15/2024 | Date when 3,416 RSUs were granted under the 2015 Plan, which subsequently vested on June 15, 2025. |
| 06/15/2025 | Date of all reported transactions: vesting of 3,416 RSUs, acquisition of 3,416 ordinary shares, disposition of 410 ordinary shares for tax, and acquisition of 4,042 new RSUs. |
| 06/17/2025 | Date the Form 4 was signed by the Attorney-in-Fact. |
| 06/15/2026 | Scheduled vesting date for the 4,042 RSUs granted under the 2025 Plan, subject to continued service. |
Keywords
LivaNova PLC, LIVN, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Share Disposition, Director Compensation, Equity Ownership, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.